| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 156 | 9,000 | 0.00% | ||
| 2 | Gilead Sciences, Inc. | 278 | 27,000 | 0.00% | Call | |
| 3 | ZAFGEN INC COM | 13,307 | 84,000 | 0.00% | ||
| 4 | RMR GROUP INC | 7,441 | 107,000 | 0.00% | ||
| 5 | XENCOR INC COM | 20,000 | 292,000 | 0.01% | ||
| 6 | CHIMERIX INC | 47,800 | 428,000 | 0.02% | ||
| 7 | GENMARK DIAGNOSTICS INC. | 93,349 | 724,000 | 0.03% | ||
| 8 | CIDARA THERAPEUTICS INC | 52,500 | 901,000 | 0.03% | ||
| 9 | BELLICUM PHARMACEUTICALS INCORPORATED | 60,000 | 1,216,000 | 0.04% | ||
| 10 | GALAPAGOS NV | 20,000 | 1,258,000 | 0.05% | ||
| 11 | CELLDEX THERAPEUTICS INC NEW | 105,800 | 1,659,000 | 0.06% | ||
| 12 | NEVRO CORP COM | 25,000 | 1,688,000 | 0.06% | ||
| 13 | TETRAPHASE PHARMACEUTICALS INC COM | 192,322 | 1,929,000 | 0.07% | ||
| 14 | GW PHARMACEUTICALS PLC | 30,000 | 2,083,000 | 0.08% | ||
| 15 | AFFIMED N V COM | 294,213 | 2,095,000 | 0.08% | ||
| 16 | MERRIMACK PHARMACEUTI | 1,485,000 | 2,199,000 | 0.08% | PRN | |
| 17 | MOMENTA PHARMACEUTICALS INC | 153,700 | 2,281,000 | 0.08% | ||
| 18 | Esperion Therapeutics Inc | 102,800 | 2,288,000 | 0.08% | ||
| 19 | DBV TECHNOLOGIES S A | 65,600 | 2,382,000 | 0.09% | ||
| 20 | KITE PHARMA INCORPORATED | 41,000 | 2,526,000 | 0.09% | ||
| 21 | CARE CAP PPTYS INC | 84,316 | 2,578,000 | 0.09% | ||
| 22 | FORWARD PHARMA A/S | 136,547 | 2,594,000 | 0.09% | ||
| 23 | LEXICON PHARMACEUTICALS INC | 197,641 | 2,631,000 | 0.10% | ||
| 24 | ALLSCRIPTS HEALTHCARE SOLUTN | 173,600 | 2,670,000 | 0.10% | ||
| 25 | GRIFOLS S A SP ADR REP B | 83,000 | 2,689,000 | 0.10% | ||
| 26 | CYNAPSUS THERAPEUTICS INC | 180,407 | 2,785,000 | 0.10% | ||
| 27 | INSMED INC | 156,600 | 2,842,000 | 0.10% | ||
| 28 | FLEX PHARMA INC COM | 232,600 | 2,896,000 | 0.11% | ||
| 29 | UNIQURE NV | 175,500 | 2,903,000 | 0.11% | ||
| 30 | NOVAVAX INC COM | 358,000 | 3,004,000 | 0.11% | ||
| 31 | BLUEBIRD BIO INC COM | 49,345 | 3,169,000 | 0.11% | ||
| 32 | HALOZYME THERAPEUTICS INC | 200,000 | 3,466,000 | 0.13% | ||
| 33 | ALLIQUA BIOMEDICAL INC | 1,650,000 | 3,531,000 | 0.13% | ||
| 34 | ADAPTIMMUNE THERAPEUTICS PLC | 296,934 | 3,581,000 | 0.13% | ||
| 35 | DEPOMED INC | 200,000 | 3,626,000 | 0.13% | ||
| 36 | ARCA BIOPHARMA INCORPORATED COM PAR .001 | 811,227 | 3,772,000 | 0.14% | ||
| 37 | SAGENT PHARMACEUTICALS INC | 286,650 | 4,561,000 | 0.17% | ||
| 38 | MALLINCKRODT PUB LTD CO | 61,900 | 4,620,000 | 0.17% | ||
| 39 | INOTEK PHARMACEUTICALS CORP | 425,000 | 4,815,000 | 0.17% | ||
| 40 | TENET HEALTHCARE CORP | 164,500 | 4,984,000 | 0.18% | ||
| 41 | ALLERGAN PLC | 5,000 | 5,151,000 | 0.19% | ||
| 42 | FOAMIX PHARMACEUTICALS LTD | 652,145 | 5,289,000 | 0.19% | ||
| 43 | HEALTHCARE RLTY TR | 187,224 | 5,302,000 | 0.19% | ||
| 44 | SUPERNUS PHARMACEUTICALS INC | 2,000,000 | 5,356,000 | 0.19% | PRN | |
| 45 | PERRIGO CO PLC | 37,300 | 5,397,000 | 0.20% | ||
| 46 | AKORN INCORPORATED | 145,235 | 5,419,000 | 0.20% | ||
| 47 | ENDOLOGIX INC | 551,000 | 5,455,000 | 0.20% | ||
| 48 | ACCELERATE DIAGNOSTICS INC | 264,625 | 5,687,000 | 0.21% | ||
| 49 | SAGE THERAPEUTICS INC | 97,800 | 5,702,000 | 0.21% | ||
| 50 | EXELIXIS INC | 1,023,877 | 5,775,000 | 0.21% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-094941, filed 2016.02.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
